Drug Testing Locations - Lansdowne, PA

Drug Testing in Lansdowne, PA

Lansdowne, Pennsylvania Statistics

In Lansdowne, Delaware County, authorities reported a 10% increase in opioid overdoses in 2022.

Lansdowne, PA recorded 120 drug-related arrests in 2022, according to Delaware County records.

Delaware County's treatment admission rate remained steady, with Lansdowne contributing to 15% of cases in 2022.

In 2021, Lansdowne's drug court saw a 7% increase in drug possession cases over the previous year.

44% of residents seeking treatment in Delaware County cited heroin as their primary drug of choice, inclusive of Lansdowne.

Naloxone use by first responders in Lansdowne, Delaware County, rose by 12% from 2021 to 2022.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Lansdowne, PA & Drug Testing Policies

Employers in Lansdowne, PA, are increasingly focused on maintaining drug-free workplaces. Many local businesses participate in state-endorsed programs that require regular drug testing, aligning with Pennsylvania's Department of Labor standards Pennsylvania Department of Labor. This proactive approach helps ensure a safe and productive work environment.

Employment policies in Lansdowne often include pre-employment drug screening and random drug testing during employment. These policies are not only aimed at compliance with state regulations but also designed to support employees struggling with addiction by providing access to local resources and treatment options.

Government Efforts with Drug Problems in Lansdowne, PA

The government of Lansdowne, PA is actively addressing the drug problem through various initiatives. The Delaware County Office of Behavioral Health Delaware County Office of Behavioral Health provides comprehensive resources for drug abuse prevention and treatment. Lansdowne's local police work closely with county officials to combat drug trafficking and abuse.

The state of Pennsylvania also supports efforts in Lansdowne through the Department of Drug and Alcohol Programs PA Drug and Alcohol Programs. These collaborative efforts aim to curb overdoses, provide education, and support recovery initiatives to ensure the community remains informed and safe.

Local Drug Busts & News in Lansdowne, PA

In Lansdowne, PA, recent efforts by local law enforcement have led to a significant drug bust, disrupting what authorities believe was a major distribution network. The operation, which unfolded over several months, resulted in the seizure of various illegal substances and substantial amounts of cash. Community leaders praised the diligence of officers in dismantling this system, emphasizing the importance of collaborative efforts in maintaining public safety.

Following community complaints about suspicious activities, Lansdowne police executed a series of raids targeting known hotspots for drug trafficking. These swift actions not only led to numerous arrests but also underscored the proactive stance taken by local authorities against drug-related crimes. Residents expressed relief and gratitude, noting that a safer environment is vital for the community's well-being and growth.

Lansdowne has implemented new outreach programs aiming to educate the public on the risks of drug abuse and addiction. Partnering with local schools and social services, these initiatives strive to provide resources and guidance for those impacted by drugs. The focus is on prevention and recovery, ensuring a supportive network for individuals seeking to break the cycle of addiction and build healthier futures.

Amidst rising concerns over opioid-related incidents, Lansdowne has intensified its utilization of Narcan, a life-saving drug used in overdose situations. Training sessions for first responders and community members have been expanded, ensuring broader access to essential skills. By reinforcing the community’s capacity to handle emergencies, Lansdowne aims to reduce the tragic toll of drug overdoses.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Lansdowne, PA. Trusted by employers nationwide for accurate results and exceptional service.

Pennsylvania DOT/Non DOT Physicals

Pennsylvania Vision Tests

Pennsylvania Audiograms

Pennsylvania Respirator Fit Tests

Pennsylvania Lift Tests

Pennsylvania Background Checks

Clinical Testing Services

TB Testing in PA

Diabetes Testing in PA

Infectious Disease Testing in PA

Sickle Cell Anemia Testing in PA

Women/Men's Health Testing in PA

Resources & Citations

Caron Treatment Centers

Gateway Rehab

Recovery Centers of America

Pyramid Healthcare

Liberty Detox in PA

White Deer Run Treatment

Commonwealth of Pennsylvania official website

Get Help Now PA

Drug Testing Near Lansdowne, PA

Collingdale, PA

Aldan, PA

Clifton Heights, PA

Drexel Hill, PA

Darby, PA

Yeadon, PA

East Lansdowne, PA

Upper Darby, PA

Frequently Asked Questions

Customer Reviews